Back to Search
Start Over
Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients.
- Source :
- Neuro-Oncology Advances; 2023, Vol. 5 Issue 1, p1-12, 12p
- Publication Year :
- 2023
Details
- Language :
- English
- Volume :
- 5
- Issue :
- 1
- Database :
- Complementary Index
- Journal :
- Neuro-Oncology Advances
- Publication Type :
- Academic Journal
- Accession number :
- 179073151
- Full Text :
- https://doi.org/10.1093/noajnl/vdad123